Curapath Appoints Philippe Clavel as Chief Executive Officer
VALENCIA, Spain and BOSTON, Dec. 13, 2023 /PRNewswire/ -- Curapath, a developer, manufacturer, and formulator of lipid- and polymer-based nanoparticles used in advanced therapeutic delivery technology, today announced the appointment of Philippe Clavel as Chief Executive Officer.
- VALENCIA, Spain and BOSTON, Dec. 13, 2023 /PRNewswire/ -- Curapath, a developer, manufacturer, and formulator of lipid- and polymer-based nanoparticles used in advanced therapeutic delivery technology, today announced the appointment of Philippe Clavel as Chief Executive Officer.
- Philippe has previously held leadership positions in the pharmaceutical and biotechnology industries.
- Philippe said, "I am thrilled to join Curapath and partner with innovators to improve the efficacy and safety profiles of nanoparticle delivery systems for novel therapeutics.
- I look forward to working with the exceptional Curapath team to enable customers to bring urgently needed treatments to patients across multiple disease areas."